Letter to the editor of radiotherapy and oncology regarding the article “Carbon ion radiotherapy for sacral chordoma: a retrospective nationwide multicentre study in Japan” by Demizu el al

Chordoma is a rarely low to intermediate malignant tumor arising from the notochordal remnants. This tumor has a high risk of local recurrence and poorly responds to traditional radiotherapy and chemotherapy. To today, complete or en-bloc resection with widely negative margins is considered to be the standard treatment for chordoma. Despite the improvement of surgical techniques and adjuvant radiotherapy, the clinical outcomes in chordoma is still dismal. Recently, we read with great interest the article by Demizu et al[1].
Source: Radiotherapy and Oncology - Category: Radiology Authors: Tags: Letter to the Editor Source Type: research